Neurizon Therapeutics LimitedASX: NUZ

Prospectus

· Issued by Neurizon Therapeutics Limited

Filed with ASX · · 32 pages · English

For the offer of a pro-rata non-renounceable entitlement issue of up to approximately 79,228,096 Entitlement Options, on the basis of 1 Entitlement Option for every 4 Shares held by Eligible Shareholders at an issue price of 1 cent per Entitlement Option, to raise up to approximately $792,281 Offer closes at 5:00pm WST on 2 November 2021 This document is a transaction specific prospectus issued in

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases